Evolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancer
- PMID: 22343234
- DOI: 10.1097/GRF.0b013e318248050d
Evolution of the Gynecologic Oncology Group protocols in the treatment of epithelial ovarian cancer
Abstract
This chapter reviews some of the sentinel Gynecologic Oncology Group (GOG) ovarian trials, describes their rationale, provides summary tables for reference, and is organized into early ovarian cancer (GOG 1, 7601, 7602, 95, 157, 175, 212), advanced ovarian cancer optimal (2, 25, 52, 104, 114, 158, 172, 182, 178, 212, 252), and suboptimal disease (3, 22, 47, 97, 111, 162, 182, 218, 252, 262).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical